{"schema_version":"secwatch.filing_event.v1","accession":"0001031203-24-000040","form_type":"8-K","ticker":"GPI","cik":"0001031203","company_name":"GROUP 1 AUTOMOTIVE INC","filed_at":"2024-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.944479+00:00","generated_at":"2026-06-01T18:30:52.527470+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Group 1 stockholders approve 2024 ESPP and 2024 Long-Term Incentive Plan at annual meeting","bullets":["2024 ESPP approved; shares available increased, term extended to May 24, 2034.","2024 Long-Term Incentive Plan approved, authorizing 700,000 shares for awards through May 15, 2034.","All nine director nominees elected; votes ranged from 10.7M to 11.5M for, with broker non-votes of 1.17M.","Non-binding say-on-pay approved with 11.2M for, 269K against; auditor Deloitte ratified with 12.7M for."],"urls":{"canonical":"https://secwatch.observer/filing/0001031203-24-000040","json":"https://secwatch.observer/filing/0001031203-24-000040.json","markdown":"https://secwatch.observer/filing/0001031203-24-000040.md","text":"https://secwatch.observer/filing/0001031203-24-000040.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/gpi-20240515.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T18:30:52.527470+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"15fc65001c87f20af2cdcd62026812e48adc504c","claim":"GROUP 1 AUTOMOTIVE INC shareholders approved Advisory vote on compensation of Named Executive Officers at the 2024-05-15 meeting.","evidence_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","confidence":0.9},{"claim_id":"720aea13f632c84d47cb4c3cf6f5f7a4df36b2b8","claim":"GROUP 1 AUTOMOTIVE INC shareholders approved Approval of 2024 Plan including authorization of 700,000 shares and term extension at the 2024-05-15 meeting.","evidence_excerpt":"Proposal 5: The 2024 Plan was approved, including the authorization of 700,000 shares to be used for awards and the extension of the term thereof to May 15, 2034, based on the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","confidence":0.9},{"claim_id":"97be6c4a19583c518cd65fccbae29095d74058b3","claim":"GROUP 1 AUTOMOTIVE INC shareholders approved Approval of 2024 ESPP including share increase and term extension at the 2024-05-15 meeting.","evidence_excerpt":"Proposal 4: The 2024 ESPP was approved, including the increase to the number of shares available for issuance under the 2024 ESPP and extension of the term thereof to May 24, 2034, based on the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","confidence":0.9},{"claim_id":"c7edb91d744e35a038c3ef98c44cdeabe2d96efa","claim":"GROUP 1 AUTOMOTIVE INC shareholders approved Election of nine director nominees at the 2024-05-15 meeting.","evidence_excerpt":"Proposal 1: The nine director nominees named in the Proxy Statement were elected as directors to serve until the 2025 Annual Meeting of Stockholders or until their successors are duly elected and qualified, based upon the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","confidence":0.9},{"claim_id":"ebb3ead15f00cabcd355cd226f5ce46547537cdf","claim":"GROUP 1 AUTOMOTIVE INC shareholders approved Ratification of Deloitte & Touche LLP as independent auditor at the 2024-05-15 meeting.","evidence_excerpt":"Proposal 3: The ratification of Deloitte & Touche LLP to serve as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2024, was approved, based upon the following votes:","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","confidence":0.9}],"comparable_filings":[{"accession":"0001171843-26-003877","ticker":"HBIO","company_name":"HARVARD BIOSCIENCE INC","filed_at":"2026-06-02T20:01:17+00:00","headline":"Stockholders approve 400,000-share increase in 2021 Incentive Plan and amendment to ESPP","event_type":"other","sec_items":["5.02","5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003877","json":"https://secwatch.observer/filing/0001171843-26-003877.json","markdown":"https://secwatch.observer/filing/0001171843-26-003877.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/0001171843-26-003877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/f8k_060226.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"Proposal 4 – Approval of the Amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan The Company’s stockholders approved the amendment to the Harvard Bioscience, Inc. Employee Stock Purchase Plan to increase the number of authorized shares of common stock available for issuance thereunder, as follows: Votes For Votes Against Votes Abstained Broker Non-Votes 1,705,565 90,905 32,521 970,538","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1123494/000117184326003877/0001171843-26-003877-index.htm"}},{"accession":"0001171843-26-003793","ticker":"EDSA","company_name":"Edesa Biotech, Inc.","filed_at":"2026-05-29T20:15:18+00:00","headline":"Edesa Biotech shareholders approve equity plan amendment adding 750K shares","event_type":"other","sec_items":["5.02","5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.02, 5.07, 9.01","same event type: other","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-003793","json":"https://secwatch.observer/filing/0001171843-26-003793.json","markdown":"https://secwatch.observer/filing/0001171843-26-003793.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/0001171843-26-003793-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/f8k_052226.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"Proposal No. 3 - Approval of Amendment to the 2019 Equity Incentive Compensation Plan The shareholders approved an amendment to the Company’s 2019 Plan to (i) increase the number of shares available for issuance thereunder plan by 750,000 shares and (ii) eliminate the annual per participant option grant limit. For Against Abstain Broker Non-Votes 2,613,551 130,589 10,680 2,147,101","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326003793/0001171843-26-003793-index.htm"}},{"accession":"0001193125-26-253825","ticker":"ACIW","company_name":"ACI WORLDWIDE, INC.","filed_at":"2026-06-02T21:08:06+00:00","headline":"ACI Worldwide annual meeting approves all proposals including director elections","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.0,"calibrated_materiality_score":0.0,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253825","json":"https://secwatch.observer/filing/0001193125-26-253825.json","markdown":"https://secwatch.observer/filing/0001193125-26-253825.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/935036/000119312526253825/0001193125-26-253825-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/935036/000119312526253825/d92029d8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"The stockholders approved, on an advisory basis, the named executive compensation as described in the 2026 Proxy Statement.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/935036/000119312526253825/0001193125-26-253825-index.htm"}},{"accession":"0001193125-26-253604","ticker":"KYTX","company_name":"Kyverna Therapeutics, Inc.","filed_at":"2026-06-02T20:30:16+00:00","headline":"Kyverna Therapeutics shareholders elect Ian Clark and Christi Shaw as Class II directors, ratify BDO USA auditor","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.15,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253604","json":"https://secwatch.observer/filing/0001193125-26-253604.json","markdown":"https://secwatch.observer/filing/0001193125-26-253604.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/0001193125-26-253604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/kytx-20260527.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"Director Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 31,505,902 3,255,231 9,225,874 Christi Shaw 34,528,865 232,268 9,225,874","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1994702/000119312526253604/0001193125-26-253604-index.htm"}},{"accession":"0001104659-26-069461","ticker":"PARK","company_name":"Park Dental Partners, Inc.","filed_at":"2026-06-02T20:05:32+00:00","headline":"Park Dental Partners announces shareholder voting results at 2026 annual meeting","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.1,"calibrated_materiality_score":0.1,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069461","json":"https://secwatch.observer/filing/0001104659-26-069461.json","markdown":"https://secwatch.observer/filing/0001104659-26-069461.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2069604/000110465926069461/0001104659-26-069461-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2069604/000110465926069461/tm2616585d1_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"The Company’s shareholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/2069604/000110465926069461/0001104659-26-069461-index.htm"}},{"accession":"0000950103-26-008321","ticker":"ADCT","company_name":"ADC Therapeutics SA","filed_at":"2026-06-02T20:01:37+00:00","headline":"ADC Therapeutics shareholders approve capital range increase, equity plan expansion at 2026 AGM","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0000950103-26-008321","json":"https://secwatch.observer/filing/0000950103-26-008321.json","markdown":"https://secwatch.observer/filing/0000950103-26-008321.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1771910/000095010326008321/0000950103-26-008321-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1771910/000095010326008321/dp247757_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"Proposal #12 : Approving amendments to articles 4a, 4b and 4c of the articles of association to increase the Company’s capital range (article 4a), conditional share capital for employee participation (article 4b) and conditional share capital for financing, acquisitions and other purposes (article 4c) as well as the introduction of article 4d regarding a conditional share capital based on the capital range The shareholders approved (i) amendments to article 4a paragraph 1 of the articles of association to increase the Company’s capital range from CHF 8,375,974.48 (lower limit) to CHF 12,354,128.80 (upper limit) to CHF 10,378,109.12 (lower limit) to CHF 15,567,163.68 (upper limit) (Proposal #12a), (ii) amendments to article 4b paragraph 1 of the articles of association to increase the Company’s conditional share capital for employee participation from 9,887,629 common shares (CHF 791,010.32) to 16,836,253 common shares (CHF 1,346,900.24) (Proposal #12b)","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1771910/000095010326008321/0000950103-26-008321-index.htm"}},{"accession":"0001104659-26-069446","ticker":"SGA","company_name":"SAGA COMMUNICATIONS INC","filed_at":"2026-06-02T20:00:26+00:00","headline":"Saga Communications shareholders elect all 7 directors, approve say-on-pay and auditor ratification","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.25,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069446","json":"https://secwatch.observer/filing/0001104659-26-069446.json","markdown":"https://secwatch.observer/filing/0001104659-26-069446.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/886136/000110465926069446/0001104659-26-069446-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886136/000110465926069446/sga-20260601x8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"The seven nominees for election as directors for the ensuing year, and until their successors are elected and qualified, were elected and received the following votes:","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/886136/000110465926069446/0001104659-26-069446-index.htm"}},{"accession":"0001104659-26-068996","ticker":"XBP","company_name":"XBP Global Holdings, Inc.","filed_at":"2026-06-01T21:00:49+00:00","headline":"XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay","event_type":"other","sec_items":["5.07","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.15,"match_reasons":["same fact type: shareholder_vote","same SEC item: 5.07, 9.01","same event type: other"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-068996","json":"https://secwatch.observer/filing/0001104659-26-068996.json","markdown":"https://secwatch.observer/filing/0001104659-26-068996.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1839530/000110465926068996/0001104659-26-068996-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1839530/000110465926068996/tm2616124d2_8k.htm"},"side_by_side_evidence":{"fact_type":"shareholder_vote","source_excerpt":"Proposal 2: The compensation of the Company’s Named Executive Officers was approved, on a non-binding advisory basis, based upon the following votes:","source_evidence_url":"https://www.sec.gov/Archives/edgar/data/1031203/000103120324000040/0001031203-24-000040-index.htm","comparable_excerpt":"Proposal 4 — To consider and vote upon a proposal to approve, on an advisory (non-binding) basis, the frequency of future say-on-pay votes: Votes For 1 Year Votes For 2 Years Votes For 3 Years Votes Abstained Broker Non-Votes 9,200,507 333 488 332,030 577,920","comparable_evidence_url":"https://www.sec.gov/Archives/edgar/data/1839530/000110465926068996/0001104659-26-068996-index.htm"}}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}